Dysregulation of these pathways, such as overexpression of anti-apoptotic proteins (e.g., Bcl-2) or loss of pro-apoptotic regulators (e.g., p53), allows cancer cells to evade apoptosis and resist treatments [54,55]. The gene discussed is TP53; the disease is cancer.